Free public records show Zhejiang Novus Pharmaceutical in 1 of the markets we cover. It is not a key player in our research.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Markets we cover where free public records show Zhejiang Novus Pharmaceutical: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Zhejiang Novus Pharmaceutical is in.
Stories on the topics Zhejiang Novus Pharmaceutical works in.
More than 90% of US women and 97% of men do not eat enough fibre. Prebiotics are the fibres that feed helpful…
Read
Gut health is one of the biggest wellness trends. Probiotics help in some cases, but not all products or…
Read
TB killed 1.23 million people in 2024. WHO now recommends rapid molecular tests first, bringing lab-grade…
ReadSearch all reports for Zhejiang Novus Pharmaceutical All companies